Concepedia

Hitomi Hosoya

HH

18

Publications

1K

Citations

15

H-Index

2012

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Stanford University

Moffitt Cancer Center

Harvard University

Cleveland Clinic

Hitomi Hosoya is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2012–2025

18

Publications

18

PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA <i>PCA3</i>

Ahmad Salameh, Alessandro K. Lee, Marina Cardó‐Vila et al. · Proceedings of the National Academy of Sciences · 2015 · 270 citations · Full text

, , +15

Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas

Brian J. Sworder, David M. Kurtz, Stefan Alig et al. · Cancer Cell · 2022 · 119 citations · Full text

, , +7

Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma

Jennifer M. Logue, Lauren C. Peres, Hamza Hashmi et al. · Blood Advances · 2022 · 94 citations · Full text

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

Surbhi Sidana, Krina K. Patel, Lauren C. Peres et al. · Blood · 2024 · 92 citations · Full text

Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release

Hitomi Hosoya, Andrey S. Dobroff, Wouter H. P. Driessen et al. · Proceedings of the National Academy of Sciences · 2016 · 67 citations · Full text

Rows per page

1–5 of 18